- Tytuł:
- Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
- Autorzy:
- Źródło:
- Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 496-508. Date of Electronic Publication: 2022 Oct 20.
- Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Crohn Disease */drug therapyCrohn Disease */chemically induced
Inflammatory Bowel Diseases*/drug therapy
Humans ; Quality of Life ; Antibodies, Monoclonal/adverse effects ; Fatigue/chemically induced ; Treatment Outcome
Czasopismo naukowe